SETD7 Drives Cardiac Lineage Commitment through Stage-Specific Transcriptional Activation.

Area of Science:

• Epigenetics
• Molecular Biology
• Developmental Biology

Background:

• Cardiac development involves complex epigenetic regulation.
• The precise roles of epigenetic enzymes in cardiac lineage specification are not fully understood.

Purpose of the Study:

• To elucidate the mechanism by which the H3K4 methyltransferase SETD7 controls cardiac differentiation.
• To investigate SETD7's interactions and target genes during cardiomyocyte development.

Main Methods:

• Chromatin immunoprecipitation sequencing (ChIP-seq) to identify SETD7 target genes.
• Analysis of SETD7 interactions with co-factors like SWI/SNF and NKX2.5.
• Assessment of SETD7's impact on gene transcription and cardiomyocyte function.

Main Results:

• SETD7 regulates cardiac differentiation by binding H3K36 marks, independent of its enzymatic activity.
• SETD7 targets distinct gene sets at different stages, interacting with SWI/SNF and NKX2.5.
• SETD7 facilitates RNA polymerase II-dependent transcription and its abnormal expression impairs cardiomyocyte function.

Conclusions:

• SETD7 plays sequential roles in cardiac lineage commitment.
• SETD7's function involves crosstalk between epigenetic marks and chromatin modifiers.
• Understanding SETD7's mechanism provides insights into cardiac development and epigenetic regulation.